• Filipin III: Advancing Membrane Cholesterol Visualization Wo

  2026-07-22

  Filipin III, a polyene macrolide antibiotic, is the gold standard for membrane cholesterol detection, enabling high-resolution visualization of cholesterol-rich domains in cell biology and immunometabolic research. Leveraging APExBIO’s Filipin III unlocks robust, reproducible workflows for mapping cholesterol dynamics in tumor microenvironments, with unique advantages in sensitivity and assay adaptability.

• Baicalein: Applied Workflows for Cancer and Inflammation Mod

  2026-07-22

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) is a research-grade flavonoid that enables precision inhibition of the 12-LOX pathway, empowering studies in cancer biology and inflammation. This guide delivers actionable protocols, troubleshooting insights, and advanced application strategies, clarifying how to maximize reproducibility and scientific value with Baicalein from APExBIO.

• Miltefosine Induces Neutrophil Differentiation via Ras/MEK/E

  2026-07-21

  The reference study demonstrates that Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) promotes neutrophil differentiation and recovery from leukopenia by activating the Ras/MEK/ERK pathway. These mechanistic insights offer a distinct therapeutic approach for immunosuppressed and hematology research models.

• Mitophagy Enhancement Attenuates Gouty Arthritis via Pyropto

  2026-07-21

  This study demonstrates that ajugol alleviates acute gouty arthritis by restoring PINK1/Parkin-mediated mitophagy and suppressing chondrocyte pyroptosis, primarily through PI3K/AKT/mTOR pathway inhibition. The findings highlight mitophagy as a promising therapeutic target for inflammatory joint disease.

• Brefeldin A (SKU B1400): Scenario-Driven Laboratory Solution

  2026-07-20

  This article delivers scenario-based guidance for integrating Brefeldin A (SKU B1400) into cell viability, ER stress, and apoptosis workflows. Drawing on validated protocols, literature, and vendor comparisons, it demonstrates how APExBIO’s Brefeldin A improves reproducibility, sensitivity, and reliability in biomedical research.

• Dual Regulation of SPRY4 Palmitoylation in Cisplatin-Resista

  2026-07-20

  This study reveals how palmitoylation cycling of Sprouty 4, regulated by ZDHHC7 and PPT1, drives cisplatin resistance in osteosarcoma. Inhibiting PPT1 with GNS561 sensitizes resistant cells to cisplatin, suggesting a promising therapeutic strategy for overcoming chemoresistance.

• Cisplatin-Induced Pyroptosis via GSDME in Gastric Cancer Cel

  2026-07-19

  This study uncovers how cisplatin promotes pyroptosis in gastric cancer cells by activating the GSDME gene, linking this pathway to both cell death and poorer prognosis. The findings expand knowledge of cisplatin's mechanisms beyond apoptosis, suggesting new avenues for overcoming chemotherapy resistance.

• AZD8055: Technical Application Guide for mTOR Inhibition

  2026-07-18

  AZD8055 provides a potent, selective tool for investigating mTOR signaling pathways in preclinical cellular and animal models. It is suitable for studies requiring precise, ATP-competitive inhibition of both mTORC1 and mTORC2, but should not be used when clinical efficacy is the primary outcome. Researchers should follow product-based handling and workflow best practices to ensure reproducibility and data quality.

• SR 11302: AP-1 Blockade for Targeted Tumor Suppression

  2026-07-17

  Explore the unique advantages of SR 11302, a selective AP-1 transcription factor inhibitor, in precise tumor suppression and chemoprevention. This article delves into its mechanism, selectivity, and emerging roles in modulating tumor immunity—offering practical guidance for advanced cancer research.

• Strategic Use of BAPTA in Deciphering Apoptosis Pathways

  2026-07-17

  A deep-dive for translational researchers into how BAPTA, a high-affinity calcium chelator, is revolutionizing the experimental dissection of apoptosis under complex environmental co-exposures. Drawing on the latest mechanistic findings, this article provides actionable insights and protocol guidance for leveraging BAPTA in advanced calcium signaling and cell death models—outlining both the scientific rationale and strategic utility for next-generation translational workflows.

• In Vitro Antibacterial Spectrum of Leucomycin: Insights and

  2026-07-16

  This article reviews the foundational 1962 study by Iwata and Akiba on the in vitro antibacterial activity of leucomycin, emphasizing its spectrum against both susceptible and erythromycin-resistant bacteria. The work's systematic approach informs modern research on macrolide antibiotics and underpins protocol strategies for addressing antibacterial drug resistance.

• ATRX-Deficient Glioma Cells—Sensitivity to RTK and PDGFR Inh

  2026-07-16

  This study uncovers that high-grade glioma cells deficient in ATRX are particularly sensitive to multi-targeted RTK and PDGFR inhibitors. The findings suggest incorporating ATRX mutation status into clinical trial interpretations and open new avenues for tailored therapeutic strategies in aggressive gliomas.

• Rimonabant (SR141716): Precision in Appetite Regulation Rese

  2026-07-15

  Rimonabant (SR141716) empowers researchers to dissect the endocannabinoid system with high CB1 selectivity, offering reproducible control over appetite and energy balance in both in vitro and in vivo models. This article details advanced workflows, protocol optimizations, and troubleshooting strategies that set SR141716 apart for obesity and neurobiology research.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Mecha

  2026-07-15

  The referenced study establishes moesin (MSN) as a critical biomarker of endothelial injury in sepsis, linking its serum levels with disease severity. By dissecting the mechanistic pathways, the research advances our understanding of vascular dysfunction in sepsis and highlights new avenues for biomarker-driven evaluation.

• NHS-Biotin Workflows for Robust Protein Labeling & Purificat

  2026-07-14

  NHS-Biotin’s amine-reactivity and membrane permeability unlock precise, stable protein labeling for detection, purification, and advanced engineering. Discover protocol optimizations, troubleshooting strategies, and key innovations inspired by recent multimeric nanobody research.

15655 records 1/1044 page Next 12345 下5页 Last page